Connect with us


Labour MPs call for possible regulation of a legalised cannabis market



A group of Labour MPs are calling for the decriminalisation of drugs and the possible regulation of the UK cannabis market.

The party’s drug policy reform group has urged Labour to take a ‘better approach’ to the war on drugs in the UK.

This includes ending the criminalisation of those who use drugs and ‘exploring the potential’ of a legalised and regulated cannabis market.

In a report published on Wednesday 23 September, the Labour Campaign for Drug Policy Reform (LCDPR), which was established in 2018 by MPs Jeff Smith MP and Thangam Debonnaire – now shadow housing minister – set out its recommendations for party policy.

It called for MPs to support a ‘public health-based approach to drug use’ and to back police schemes to decriminalise those found in possession of drugs.

It also reported a need to expand research programmes into ‘medicines derived from controlled drugs’ and encouraged politicians to ‘engage seriously’ with worldwide discussions to ‘explore the potential’ of regulating the UK cannabis market.

Highlighting the need to build a fair criminal justice system, the group urged Police and Crime Commissioners and Mayors around the country to look at local law enforcement and make it clear that those possessing or cultivating cannabis to meet a ‘genuine medical need’ should not be charged.

The report said: “One of the main factors impeding efforts to help people who use drugs to stay healthy, and to support their recovery, is the criminalisation and stigma attached to all drug use.

“Arresting and punishing people who use drugs costs the taxpayer hundreds of millions of pounds per year, gives criminal records to tens of thousands of otherwise law-abiding people, and makes it harder for those struggling with addiction to access help and turn their lives around.”

It added: “Labour should therefore be clear that it will end the criminalisation of people who use drugs and make this a matter for public health, not the criminal justice system.”

The reports recommendations are the result of a number of public meetings across the UK, attended by hundreds, and are supported by a number of Labour MPs and MSPs, including several shadow cabinet ministers.

It has been described as a ‘progressive move’ by drug reform campaigners and welcomed by those advocating for patients to have wider access to medical cannabis.

Former chief drugs advisor to then-Prime Minister Gordon Brown and now chair of the Drug Science scientific committee, Professor David Nutt, commented: “Drug Science welcomes this progressive move by Labour that appreciates the reality of the current failed system and recommends evidence-based alternatives.”

Another of those who showed their support for the recommendations is Carly Barton, the first UK patient to receive a private prescription for medical cannabis and the founder of Cancard, a new scheme due to launch in November to protect medical cannabis patients from arrest and prosecution.

Carly told Cannabis Health that Cancard was set up with the full backing of cross-party delegates, including many Labour MPs.

“Cancard exists to prevent needless arrests of people who are consuming medicine simply to be well,” she said.

“We are in support of the latest Labour Party recommendations, they couldn’t be more clear on this issue. Patients are at the end of being able to tolerate anymore fear around criminalisation, MPs can’t justify it and Police don’t want to be in the situation that they find themselves in.

Carly added: “We will continue to work with all political groups to ensure the patient’s voice is heard and we are more effective at making the necessary changes in law.”

Responding to the report on Twitter, Detective Chief Inspector Jason Kew, the Thames Valley Police lead for Drugs, Exploitation and Harm Reduction, who is also backing the Cancard scheme, added: “An awful lot of evidence based sense here. I wish, apolitically, that drug policy wasn’t politicised.

“Great to read a commitment to explore what works internationally and supervised injecting facilities are prioritised too.”



Fair Trials and Last Prisoner Project seek to launch global cannabis justice project

Fair Trials’ Global CEO Norman L. Reimer to discuss the project at Cannabis Europa Conference in London on June 29.



fair trials cannabis justice

A new initiative from Fair Trials and the Last Prisoner Project aims to redress the harm caused by cannabis prohibition and to secure relief for those in prison for cannabis-related convictions.

The criminal justice reform NGO, Fair Trials hopes that the industry will support its work in countries across the globe where cannabis laws are being liberalised. Through collaboration with local partners in appropriate jurisdictions, the Fair Trials project will identify people in need of legal assistance, and recruit, train and match volunteer lawyers to take on their cases.

Fair Trials has enlisted the help of the Last Prisoner Project, a coalition of cannabis industry leaders, executives and artists dedicated to bringing restorative justice to the cannabis sector.

More and more jurisdictions are allowing adults to use and distribute medical and recreational cannabis. But after decades of prohibition, countless people remain behind bars or continue to suffer the collateral consequences of a cannabis conviction.

US research programme studies cannabinoids in ovarian cancer

“The injustice of cannabis prohibition has resulted in millions of people worldwide serving time in prison or being saddled with a cannabis conviction, which brings with it a lifetime of harmful consequences, ranging from education and employment opportunities to immigration status and parental rights,” said Fair Trials Global CEO, Norman L Reimer.

“Of course, these harmful effects of prohibition not only impact the individuals charged, but also their families and communities. And those effects have been borne disproportionately by minorities, communities of colour, and the socio-economically disadvantaged. Legalising cannabis alone does not equal justice. Together, we must address the ongoing harms of past prohibition and leave no cannabis prisoner behind.”

The project will be modelled on the US Cannabis Justice Initiative, a collaborative effort between the cannabis industry and volunteer lawyers in the United States. When Norman Reimer was the Executive Director of the National Association of Criminal Defense Lawyers (NACDL), he partnered with the Last Prisoner Project to establish the initiative.

“Key to the success of the initiative has been generous donations from legal cannabis companies and consumers nationwide,” said Last Prisoner Project Co-Founder Steve DeAngelo. “Fair Trials, with its global reach as the world’s criminal justice watchdog, is uniquely positioned to build and house the infrastructure that’s going to be needed.”

Tomorrow (29 June), Norman Reimer will address the Cannabis Europa Conference discussing the project. Mr Reimer will be part of a panel entitled ‘Leave No Cannabis Prisoner Behind,’ and will be joined on that panel by Mary Bailey, Managing Director at the Last Prisoner Project; Dr. Laura Garius, Policy Lead at Release; and Denzel Uba, an individual impacted by criminal cannabis prohibition.

Continue Reading


TOWIE star Amy Childs launches CBD range in honour of Jorja Foundation

The product range sees a portion of the proceeds going to the Jorja Foundation.



Amy Childs at the launch of her new CBD range, Jorja Botanicals

TOWIE star Amy Childs launched her new CBD range this week, with a star-studded event that shone a spotlight on the story of six-year-old Jorja Emerson.

Amy Childs was joined by former Love Islanders, Amy Hart and Cara Delahoyde-Massey, alongside her  co-stars, Frankie Essex, Tom Skinner, Carina Lepore, Saffron Lempriere and Mark Ferris, for a heart-warming event celebrating the launch of her new CBD Infused beauty range, Jorja Botanicals.

The signature collection sees a portion of the proceeds going to the Jorja Foundation, which was set up in honour of six-year-old medical cannabis patient, Jorja Emerson.

The event saw The Only Way Is Essex star Frankie Essex, break down in tears as she heard Jorja’s story. Frankie, who gave birth to twins four weeks ago, wiped her eyes when Robin Emerson, Jorja’s father, showed videos of the life-threatening seizures his daughter was suffering before they discovered medical cannabis

Love Island star, Amy Hart has since taken to Instagram to spread the word about the latest political campaign that sees Childs and Emerson petitioning to make medical cannabis more widely available on the NHS

The Jorja Botanicals range was inspired by Jorja, who was diagnosed with a rare chromosome abnormality called 1q43q44 deletion, which has a side effect of life-threatening seizures. Her illness resulted in her being admitted to intensive care on two separate occasions, where Robin was told that she may not make it.

jorja botanicals

TOWIE stars joined Amy Childs for the launch of her new CBD range

To save his daughter’s life, Emerson knew that he had to dig deep and find a treatment that would not only help Jorja but ultimately go on to help others.

At the time it was still illegal to prescribe cannabis in the UK. Emerson joined the campaign to see medical cannabis legalised in the UK in November 2018, and Jorja’s was among the first children to be legally prescribed medicinal cannabis.

In 2021 he went on to create the Jorja Foundation – a charity set up to help other families and children going through the same battles that Robin had to face.

The Jorja Foundation’s core principles are to fund special needs equipment that is not funded through the health system, fund family counselling, private appointments and tests when a second opinion is needed, as well s cannabis-based treatment for children in the UK and to continue to campaign and educate for wider NHS access in the UK for cannabis-based medications.  

Childs commented: “When I saw Robin & Jorja’s story on social media it broke my heart.

As a mum, I couldn’t imagine the pain of being told to take my child home to say goodbye to them. I love that Robin has fought for Jorja & is now helping other families with the Jorja Foundation. 

“I’m so happy that I can help the foundation by being the Creative Director of Jorja Botanicals. We have created some beautiful products for the whole family to enjoy. We will be donating a percentage of the proceeds to the foundation so that we can help as many families as possible. ”

 Emerson added: “ This is the fruition of a lot of hard work over many months and I am extremely proud to launch what is the first family brand in this category. In the coming weeks, we will also be launching a ‘parent’ focused cosmetic range in partnership with our creative director Amy Childs and our premium line of tincture oils.”


Home » News » Labour MPs call for possible regulation of a legalised cannabis market

Continue Reading


South Africa launches first trial of cannabis for chronic pain

The study will test whether cannabis can replace opioids in the management of chronic pain.



south africa cannabis trial

South Africa’s first cannabis trial has launched after initial results “show promise” for the treatment as a replacement for opioids.

The Pharma Ethics Observational Study is led by Biodata, a subsidiary of Labat Africa, and will test whether cannabis can replace opioids in the management of chronic pain.

The study will involve 1,000 participants who have been taking opioids for pain management for at least three months and are prepared to switch to cannabis as an alternative.

Biodata is the brainchild of Dr Shiksha Gallow, a cannabis clinician and the principal investigator in the trial which took over 18 months to get official clearance.

US research programme studies cannabinoids in ovarian cancer

Dr Gallow said the trial is set to be ground-breaking as South Africa’s first real-world study of medical cannabis. Researchers predict that it will provide much-needed insight into the link between cannabis genetics and patient outcomes.

Dr Gallow told Cannabiz Africa: “We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live Study. It has been fairly slow. However, more options have been introduced, as suggested by the patients in the pilot study.

“The pilot results of the study were very promising, as it showed 98 per cent of the patients have some sort of pain relief from the cannabis.

“We were able to wean these patients off their opioid treatment. In the pilot group of patients below the age of 55, it was shown this group preferred to smoke cannabis and patients older than 55 years preferred oil. The patients who smoked the cannabis had relief almost immediately, while the oil took some time to alleviate their pain.”

“Once we reach the sample size required and all of the relevant data has been collated, the results of the study will be published. We have currently renewed this study for another year, due to the initial slow uptake of research participants.”

Patients can apply to be research participants through the Biodata website.

Labat is expanding its footprint over the next few months with the introduction of CannAfrica kiosks in major shopping malls.

The company believes these will be the “ideal locations for physical sign-up points for the study”.

Labat said the kiosks will also serve as Biodata dispensaries and is engaging with a number of vape stores to do the same, although these would have to be subject to South African Health Products Regulatory Authority’s pharma-ethics requirements.

Home » News » Labour MPs call for possible regulation of a legalised cannabis market

Continue Reading